These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical features and histological data of chorea associated with systemic lupus erythematosus (SLE). Lusins JO; Szilagyi PA; Etess HB; Platt N; Nathanson M Trans Am Neurol Assoc; 1973; 98():279-81. PubMed ID: 4784956 [No Abstract] [Full Text] [Related]
7. Chorea as an initial manifestation of systemic lupus erythematosus. A case report of a 10-year-old girl. Arisaka O; Obinata K; Sasaki H; Arisaka M; Kaneko K Clin Pediatr (Phila); 1984 May; 23(5):298-300. PubMed ID: 6705440 [TBL] [Abstract][Full Text] [Related]
8. Biochemical mechanisms and management of choreiform movement disorders. de Silva L Drugs; 1977 Oct; 14(4):300-10. PubMed ID: 144049 [No Abstract] [Full Text] [Related]
9. Clinical features of chorea associated with systemic lupus erythematosus. Lusins JO; Szilagyi PA Am J Med; 1975 Jun; 58(6):857-61. PubMed ID: 1138540 [TBL] [Abstract][Full Text] [Related]
10. Haloperidol treatment of chorea associated with systemic lupus erythematosus. Heilman KM; Kohler WC; LeMaster PC Neurology; 1971 Sep; 21(9):963-5. PubMed ID: 5106258 [No Abstract] [Full Text] [Related]
11. [A case of systemic lupus erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment]. Wakasugi M; Sato T; Maruyama Y; Ueno M; Arakawa M Ryumachi; 1996 Jun; 36(3):545-50. PubMed ID: 8779791 [TBL] [Abstract][Full Text] [Related]
12. The pharmacology of choreatic movement disorders. Klawans HL; Weiner WJ Prog Neurobiol; 1976; 6(1):49-80. PubMed ID: 132681 [No Abstract] [Full Text] [Related]
13. [Use of haloperidol in the treatment of extrapyramidal compulsive movement]. Kivalo E; Weckman N Nervenarzt; 1970 Nov; 41(11):567-9. PubMed ID: 4249744 [No Abstract] [Full Text] [Related]
14. Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease. Girotti F; Carella F; Scigliano G; Grassi MP; Soliveri P; Giovannini P; Parati E; Caraceni T J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):848-52. PubMed ID: 6147393 [TBL] [Abstract][Full Text] [Related]
15. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders. Toglia JU; McGlamery M; Sambandham RR J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Huntington's chorea with lithium carbonate. A double-blind trial. Aminoff MJ; Marshall J Lancet; 1974 Jan; 1(7848):107-9. PubMed ID: 4130308 [No Abstract] [Full Text] [Related]
17. Treatment of dyskinetic and choreatic movement disorders in adults. Rosin AJ Gerontology; 1978; 24(1):46-57. PubMed ID: 145391 [No Abstract] [Full Text] [Related]
18. [Involuntary movement disorders as first manifestation of systemic lupus erythematosus: case report]. Kakehasi AM; Bomtempo CA; Vassalo S; Pimenta RC; Carvalho MA; Cardoso F Arq Neuropsiquiatr; 2001 Sep; 59(3-A):609-12. PubMed ID: 11588646 [TBL] [Abstract][Full Text] [Related]
19. Lingual-facial-buccal movements in the elderly. I. Pathophysiology and treatment. Weiner WJ; Klawans HL J Am Geriatr Soc; 1973 Jul; 21(7):314-7. PubMed ID: 4268288 [No Abstract] [Full Text] [Related]
20. Reversible chorea and parkinsonism in a patient with systemic lupus erythematosus. Kim M; Lee SM; Yoon JH Neurol Sci; 2016 Mar; 37(3):491-2. PubMed ID: 26689923 [No Abstract] [Full Text] [Related] [Next] [New Search]